Anwar Ghulam Rabbani, Mehr Muhammad Tariq, Tahir Danial, Humayun Sidra, Farooq Ghulam
Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Internal Medicine, Ayub Medical College, Abbottabad, PAK.
Cureus. 2021 Apr 8;13(4):e14372. doi: 10.7759/cureus.14372.
Castleman disease (CD) is a disorder characterized by lymphoid proliferation. It is not usually the first differential for pyrexia of unknown origin (PUO) because of the extremely rare incidence worldwide. We report the case of a 24-year-old man with PUO for six months. He had been previously investigated for infective, rheumatological, and immunological causes. Extrapulmonary tuberculosis was considered as the most likely diagnosis because of his clinical presentation and locality. Based on this, he was given a trial of anti-tuberculous therapy. However, he did not show any signs of improvement despite being compliant with the medications. His condition was further complicated by the development of ascites. Upon treatment failure, the patient presented to our tertiary care hospital and was investigated for a possible revision of diagnosis. Based on clinical assessment and histopathology of the lymph nodes, he was diagnosed with idiopathic multicentric CD overlapping with systemic lupus erythematosus. He was started on azathioprine and prednisone and showed a positive response, indicated by a decreasing erythrocyte sedimentation rate and C-reactive protein. The patient continues to be healthy and in remission to date.
卡斯特曼病(CD)是一种以淋巴组织增生为特征的疾病。由于其在全球的发病率极低,它通常不是不明原因发热(PUO)的首要鉴别诊断。我们报告一例24岁男性,不明原因发热达6个月。他之前曾针对感染性、风湿性和免疫性病因进行过检查。由于其临床表现和所在地区,肺外结核被认为是最可能的诊断。基于此,给予他抗结核治疗试验。然而,尽管他遵医嘱服药,却未显示出任何改善迹象。腹水的出现使他的病情进一步复杂化。治疗失败后,该患者到我们的三级医院就诊,并接受了可能的诊断修正检查。根据临床评估和淋巴结组织病理学检查,他被诊断为特发性多中心型卡斯特曼病合并系统性红斑狼疮。开始给予他硫唑嘌呤和泼尼松治疗,红细胞沉降率和C反应蛋白下降表明治疗有积极反应。该患者至今仍保持健康且处于缓解状态。